Regenxbio
(NASDAQ:RGNX)
$21.07
-1.11[-5.00%]
At close: Mar 28
$21.07
0[0.00%]
After Hours: 4:00PM EDT
Consensus Rating1
Buy
Highest Price Target1
$90.00
Lowest Price Target1
$14.00
Consensus Price Target1
$40.86

Regenxbio Stock (NASDAQ:RGNX), Analyst Ratings, Price Targets, Predictions

Regenxbio Inc has a consensus price target of $40.86, established from looking at the 42 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., RBC Capital, and Chardan Capital on March 11, 2024, March 8, 2024, and March 7, 2024. With an average price target of $41 between HC Wainwright & Co., RBC Capital, and Chardan Capital, there's an implied 94.59% upside for Regenxbio Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Oct 23
1
Nov 23
1
Feb
1
2
Mar
6
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
RBC Capital
Chardan Capital
Barclays
Leerink Partners

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Regenxbio

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/11/2024RGNXBuy Now
Regenxbio
$21.0770.86%HC Wainwright & Co.
Yi Chen
→ $36Initiates → BuyGet Alert
03/08/2024RGNXBuy Now
Regenxbio
$21.0766.11%RBC Capital
Luca Issi
$20 → $35UpgradeSector Perform → OutperformGet Alert
03/07/2024RGNXBuy Now
Regenxbio
$21.07146.8%Chardan Capital
Daniil Gataulin
$52 → $52MaintainsBuyGet Alert
03/07/2024RGNXBuy Now
Regenxbio
$21.07161.03%Barclays
Gena Wang
$45 → $55MaintainsOverweightGet Alert
03/06/2024RGNXBuy Now
Regenxbio
$21.07Leerink Partners
Mani Foroohar
UpgradeMarket Perform → OutperformGet Alert
03/06/2024RGNXBuy Now
Regenxbio
$21.0785.1%Baird
Brian Skorney
$34 → $39MaintainsOutperformGet Alert
02/28/2024RGNXBuy Now
Regenxbio
$21.07-0.33%Wedbush
Andreas Argyrides
→ $21ReiteratesNeutral → NeutralGet Alert
02/21/2024RGNXBuy Now
Regenxbio
$21.07113.57%Raymond James
Dane Leone
→ $45Reinstates → OutperformGet Alert
02/12/2024RGNXBuy Now
Regenxbio
$21.07-0.33%Wedbush
Andreas Argyrides
→ $21ReiteratesNeutral → NeutralGet Alert
11/01/2023RGNXBuy Now
Regenxbio
$21.0766.11%Stifel
Annabel Samimy
→ $35Initiates → BuyGet Alert
10/05/2023RGNXBuy Now
Regenxbio
$21.07-5.08%Wedbush
Andreas Argyrides
→ $20ReiteratesNeutral → NeutralGet Alert
10/04/2023RGNXBuy Now
Regenxbio
$21.07-5.08%RBC Capital
Luca Issi
→ $20ReiteratesSector Perform → Sector PerformGet Alert
08/29/2023RGNXBuy Now
Regenxbio
$21.0799.34%Morgan Stanley
Vikram Purohit
$43 → $42MaintainsOverweightGet Alert
08/03/2023RGNXBuy Now
Regenxbio
$21.07161.03%Chardan Capital
Daniil Gataulin
→ $55Reiterates → BuyGet Alert
07/12/2023RGNXBuy Now
Regenxbio
$21.07-5.08%RBC Capital
Luca Issi
→ $20ReiteratesSector Perform → Sector PerformGet Alert
06/20/2023RGNXBuy Now
Regenxbio
$21.0799.34%Baird
Brian Skorney
→ $42Initiates → OutperformGet Alert
06/02/2023RGNXBuy Now
Regenxbio
$21.0799.34%Baird
Brian Skorney
→ $42Initiates → OutperformGet Alert
05/09/2023RGNXBuy Now
Regenxbio
$21.07104.08%Morgan Stanley
Vikram Purohit
$46 → $43MaintainsOverweightGet Alert
05/05/2023RGNXBuy Now
Regenxbio
$21.07161.03%Chardan Capital
Daniil Gataulin
$61 → $55MaintainsBuyGet Alert

FAQ

Q

What is the target price for Regenxbio (RGNX)?

A

The latest price target for Regenxbio (NASDAQ: RGNX) was reported by HC Wainwright & Co. on March 11, 2024. The analyst firm set a price target for $36.00 expecting RGNX to rise to within 12 months (a possible 70.86% upside). 20 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Regenxbio (RGNX)?

A

The latest analyst rating for Regenxbio (NASDAQ: RGNX) was provided by HC Wainwright & Co., and Regenxbio initiated their buy rating.

Q

When was the last upgrade for Regenxbio (RGNX)?

A

The last upgrade for Regenxbio Inc happened on March 8, 2024 when RBC Capital raised their price target to $35. RBC Capital previously had a sector perform for Regenxbio Inc.

Q

When was the last downgrade for Regenxbio (RGNX)?

A

There is no last downgrade for Regenxbio.

Q

When is the next analyst rating going to be posted or updated for Regenxbio (RGNX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Regenxbio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Regenxbio was filed on March 11, 2024 so you should expect the next rating to be made available sometime around March 11, 2025.

Q

Is the Analyst Rating Regenxbio (RGNX) correct?

A

While ratings are subjective and will change, the latest Regenxbio (RGNX) rating was a initiated with a price target of $0.00 to $36.00. The current price Regenxbio (RGNX) is trading at is $21.07, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch